adult acute myeloid leukemia with t(15;17)(q22;q12)
Showing 51 - 75 of >10,000
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +19 more
- umbilical cord blood transplantation
- +7 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 27, 2019
Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)
Recruiting
- Core Binding Factor Acute Myeloid Leukemia
- KIT Mutation-Related Tumors
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital of Soochow University
Apr 7, 2023
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22);
Completed
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +10 more
- Erlotinib Hydrochloride
- Laboratory Biomarker Analysis
-
Houston, TexasM D Anderson Cancer Center
Dec 18, 2019
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- sargramostim
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 3, 2022
Frequency and Risk Factors of Acute Myeloid Leukemia
Not yet recruiting
- Myeloid Leukemia
- Bone marrow aspirite for diagnosis
- (no location specified)
Mar 15, 2023
Leukemia Trial in United States (arsenic trioxide, gemtuzumab ozogamicin, mercaptopurine)
Completed
- Leukemia
- arsenic trioxide
- +4 more
-
Roseville, California
- +191 more
Dec 14, 2022
Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia
Active, not recruiting
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
- +16 more
- clofarabine
- +7 more
-
Birmingham, Alabama
- +268 more
Feb 23, 2021
Leukemia, MDS Trial in Duarte (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- Myelodysplastic Syndromes
- fludarabine phosphate
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Leukemia Trial in Austria, Germany, Italy (arsenic trioxide, idarubicin, mercaptopurine)
Completed
- Leukemia
- arsenic trioxide
- +5 more
-
Innsbruck, Austria
- +109 more
Oct 10, 2022
Leukemia, MDS Trial (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- Myelodysplastic Syndromes
- busulfan
- +7 more
- (no location specified)
Feb 17, 2022
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)
Recruiting
- Brain and Central Nervous System Tumors
- +8 more
- 3'-deoxy-3'-[18F]fluorothymidine
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 30, 2022
Acute Myeloid Leukemia (AML), Multiple Myeloma (MM) Trial (3x10(6) CART-38 cellls, 7x10(5) CART-38 cells, 7x10(6) CART-38 cells)
Not yet recruiting
- Acute Myeloid Leukemia (AML)
- Multiple Myeloma (MM)
- 3x10(6) CART-38 cellls
- +5 more
- (no location specified)
Jul 15, 2022
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +11 more
- Zilovertamab vedotin
-
Duarte, California
- +13 more
Jan 12, 2023
Diagnostic Yield Among M-FISH, FISH Probe Panel and Conventional
Completed
- Acute Myeloid Leukemia
- Conventional Cytogenetics Studies
- +2 more
-
Assiut, EgyptSouth Egypt Cancer Institute
Mar 7, 2022
Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan
Recruiting
- Acute Myeloid Leukemia, Adult
- +2 more
- Fludarabine and Busulfan
- Fludarabine and Melphalan
-
Wuhan, Hubei, ChinaWuhan Union Hospital, Tongji Medical college, Huazhong Universit
Jan 5, 2023
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Active, not recruiting
- Acute Leukemia
- +3 more
- cytogenetic analysis
-
La Jolla, California
- +136 more
Aug 16, 2021
Acute Myeloid Leukemia Trial in United States (ADCLEC.syn1 CAR T cells, Conditioning chemo)
Not yet recruiting
- Acute Myeloid Leukemia
- ADCLEC.syn1 CAR T cells
- Conditioning chemotherapy
-
Basking Ridge, New Jersey
- +6 more
Mar 1, 2023
B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent
Terminated
- B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1
- +4 more
- Dasatinib
- +3 more
-
Chicago, IllinoisNorthwestern University
Jan 31, 2020
Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)
Recruiting
- Acute Myeloid Leukemia, Adult
- cladribine + homoharringtonine + cytarabine
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Jun 13, 2023
Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,
Completed
- Adult Acute Lymphoblastic Leukemia in Remission
- +9 more
- Cyclosporine
- +9 more
-
Denver, Colorado
- +2 more
Jan 17, 2020
Acute Myeloid Leukemia, Venetoclax Trial in Kunming (combination of venetoclax and HAA regimen)
Recruiting
- Acute Myeloid Leukemia
- Venetoclax
- combination of venetoclax and HAA regimen
-
Kunming, Yunnan, ChinaThe Second Affiliated Hospital of Kunming Medical University.
May 29, 2023
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute
Terminated
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +13 more
- ipilimumab
-
Boston, MassachusettsDana-Farber Cancer Institute
Sep 4, 2018
Tissue, Blood, and Body Fluid Sample Collection From Hematologic
Recruiting
- Chronic Myeloproliferative Disorders
- +7 more
- biologic sample preservation procedure
- cytology specimen collection procedure
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Oct 14, 2021